Document:

Targeted Genetics Corporation Stock Incentive Plan

 Exhibit 10.5 
 TARGETED GENETICS CORPORATION 
 STOCK INCENTIVE PLAN 
 Effective as of March 3, 2009 
  

 1 

					
	 SECTION 1.
	  	INTRODUCTION	  	3
			
	 SECTION 2.
	  	DEFINITIONS	  	3
			
	 SECTION 3.
	  	ADMINISTRATION	  	7
			
	 SECTION 4.
	  	GENERAL	  	9
			
	 SECTION 5.
	  	SHARES SUBJECT TO PLAN AND SHARE LIMITS	  	10
			
	 SECTION 6.
	  	TERMS AND CONDITIONS OF OPTIONS	  	10
			
	 SECTION 7.
	  	PAYMENT FOR OPTION SHARES	  	12
			
	 SECTION 8.
	  	TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS	  	12
			
	 SECTION 9.
	  	TERMS AND CONDITIONS FOR STOCK GRANTS.	  	13
			
	 SECTION 10.
	  	TERMS AND CONDITIONS OF STOCK UNITS	  	14
			
	 SECTION 11.
	  	PROTECTION AGAINST DILUTION	  	15
			
	 SECTION 12.
	  	EFFECT OF A CORPORATE TRANSACTION	  	16
			
	 SECTION 13.
	  	LIMITATIONS ON RIGHTS	  	16
			
	 SECTION 14.
	  	WITHHOLDING TAXES	  	17
			
	 SECTION 15.
	  	DURATION AND AMENDMENTS	  	17
			
	 SECTION 16.
	  	ADDENDA	  	18
			
	 SECTION 17.
	  	SEVERABILITY	  	18
			
	 SECTION 18.
	  	EXECUTION	  	18

  

 2 

 TARGETED GENETICS CORPORATION 
 STOCK INCENTIVE PLAN 
 EFFECTIVE AS OF MARCH 3, 2009 
 SECTION 1. INTRODUCTION. 
 On
March 26, 2007, the Board amended, restated and renamed the Targeted Genetics Corporation 1999 Stock Option Plan into the Targeted Genetics Corporation Stock Incentive Plan (the “Plan”), and the Plan became effective upon its approval
by the Company shareholders on May 17, 2007. Notwithstanding anything to the contrary, stock options granted prior to the date the Plan became effective shall be governed by the terms and provisions of the Targeted Genetics Corporation 1999
Stock Option Plan and the applicable stock option agreement. 
 The Targeted Genetics Corporation 1999 Stock Option Plan was originally
adopted by the Board on January 21, 1999 and it was thereafter approved by the Company’s shareholders on May 5, 1999. Such plan was last amended by the Board on March 22, 2004 and approved by the Company’s shareholders on
May 20, 2004. The Plan was last amended by the Board on March 3, 2009 and approved by the Company’s shareholders on May 14, 2009. 
 The purposes of the Plan are to promote the long-term success of the Company and the creation of shareholder value by offering Key Service Providers an opportunity to share in such long-term success by acquiring a
proprietary interest in the Company and to attract and retain the best available personnel for positions of substantial responsibility, and to provide additional incentive to Employees, Consultants and Directors. 
 The Plan seeks to achieve these purposes by providing for discretionary long-term incentive Awards in the form of Options (which may constitute Incentive
Stock Options or Nonstatutory Stock Options), Stock Appreciation Rights, Stock Grants and Stock Units. 
 The Plan shall be governed by, and
construed in accordance with, the laws of the State of Washington (except its choice-of-law provisions). Capitalized terms shall have the meaning provided in Section 2 unless otherwise provided in the Plan or any related Stock Option Agreement,
SAR Agreement, Stock Grant Agreement or Stock Unit Agreement. 
 SECTION 2. DEFINITIONS. 
  

	 	(a)	“Affiliate” means any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries own not less than 50% of such entity. 

  

	 	(b)	“Applicable Laws” means all applicable laws, rules, regulations and requirements, including, but not limited to, all applicable U.S. federal or state laws, any Stock
Exchange rules or regulations, and the applicable laws, rules or regulations of any other country or jurisdiction where Awards are granted under the Plan or where Participants reside or provide services, as such laws, rules, and regulations shall be
in effect from time to time. 

  

	 	(c)	“Award” means any Grant of an Option, SAR, Stock Grant or Stock Unit under the Plan. 

  

	 	(d)	“Board” means the Board of Directors of the Company, as constituted from time to time. 

  

 3 

 (e) “Cashless Exercise” means, to the extent that a Stock Option Agreement so provides and as
permitted by applicable law, a program approved by the Committee in which payment may be made all or in part by delivery (on a form prescribed by the Committee) of an irrevocable direction to a securities broker to sell Shares and to deliver all or
part of the sale proceeds to the Company in payment of the aggregate Exercise Price and, if applicable, the amount necessary to satisfy the Company’s withholding obligations at the minimum statutory withholding rates, including, but not limited
to, U.S. federal, state and local income taxes, payroll taxes, and foreign taxes, if applicable. 
 (f) “Cause” means, except as may
otherwise be provided in a Participant’s employment agreement or Award agreement, a conviction of a Participant for a felony crime or the failure of a Participant to contest prosecution for a felony crime, or a Participant’s misconduct,
fraud or dishonesty (as such terms are defined by the Committee in its sole discretion), or any unauthorized use or disclosure of confidential information or trade secrets, in each case as determined by the Committee, and the Committee’s
determination shall be conclusive and binding. 
 (g) “Change in Control” means the occurrence of any one or more of the following:

 (i) the sale, transfer or disposition of all or substantially all of the Company’s assets other than to (A) a
corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (B) a corporation or other entity owned directly or indirectly by the holders of capital stock of the Company
in substantially the same proportions as their ownership of Common Stock, or (C) an Excluded Entity (as defined in subsection (ii) below) 
 (ii) the merger, consolidation or other business combination transaction of the Company with or into another corporation, entity or person, other than a transaction with or into another corporation, entity or person
in which the holders of at least a majority of the shares of voting capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding in the continuing entity or by
their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of the Company (or the surviving entity) outstanding immediately after such
transaction (an “Excluded Entity”); or 
 (iii) the acquisition, directly or indirectly, by any person or related
group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities
of the Company representing more than 50% of the total combined voting power of the Company’s then outstanding securities pursuant to a tender or exchange offer made directly to the Company’s stockholders which the Board does not recommend
such stockholders accept. 
 A transaction (including a Corporate Transaction) shall not constitute a Change in Control if its sole purpose is
to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transactions. 

(h) “Code” means the Internal Revenue Code of 1986, as amended, and the regulations and interpretations promulgated thereunder. 

(i) “Committee” means a committee described in Section 3. 
 (j) “Common Stock” means the Company’s common stock. 
 (k) “Company” means Targeted
Genetics Corporation, a Washington corporation, and any successor. 
 (l) “Consultant” means an individual who performs bona-fide
services to the Company, a Parent, a Subsidiary or an Affiliate, other than as an Employee or Director. 
  

 4 

 (m) “Corporate Transaction” means a sale of all or substantially all of the Company’s
assets, or a merger, consolidation or other capital reorganization or business combination transaction of the Company with or into another corporation, entity or person. 
 (n) “Covered Employees” means those persons who are subject to the limitations of Section 162(m) of the Code. 
 (o) “Director” means a member of the Board. 
 (p) “Disability” means “permanent and
total disability” as such term is defined in Section 22(e)(3) of the Code. 
 (q) “Employee” means any individual who is a
common-law employee of the Company, a Parent, a Subsidiary, or an Affiliate. 
 (r) “Exchange Act” means the Securities Exchange Act
of 1934, as amended. 
 (s) “Exercise Price” means, in the case of an Option, the amount for which a Share may be purchased upon
exercise of such Option, as specified in the applicable Stock Option Agreement. “Exercise Price,” in the case of a SAR, means an amount, as specified in the applicable SAR Agreement, which is subtracted from the Fair Market Value in
determining the amount payable upon exercise of such SAR. 
 (t) “Fair Market Value” means the market price of a Share as
established in good faith by the Committee or (a) if the Common Stock is listed on the Nasdaq National Market, the closing selling price for the Common Stock as reported by the Nasdaq National Market for a single trading day or (b) if the
Common Stock is listed on the New York Stock Exchange or the American Stock Exchange, the closing selling price for the Common Stock as such price is officially quoted in the composite tape of transactions on such exchange for a single trading day.
If there is no such reported price for the Common Stock for the date in question, then such price on the last preceding date for which such price exists shall be determinative of Fair Market Value. the market price of a Share as determined in good
faith by the Committee. 
 (u) “Fiscal Year” means the Company’s fiscal year. 
 (v) “Grant” means any grant of an Award under the Plan. 
 (w) “Incentive Stock Option” or “ISO” means an incentive stock option described in Section 422 of the Code. 
 (x) “Key Service Provider” means an Employee, Director or Consultant who has been selected by the Committee to receive an Award under the Plan. 
 (y) “Non-Employee Director” means a Director who is not an Employee. 
 (z) “Nonstatutory Stock Option” or “NSO” means a stock option that is not an Incentive Stock Option. 
 (aa) “Option” means an ISO or NSO granted under the Plan entitling the Optionee to purchase Shares. 
 (bb) “Optioned Stock” means Shares that are subject to an Option or that were issued pursuant to the exercise of an Option. 
 (cc) “Optionee” means an individual, estate or other entity that holds an Option. 
  

 5 

 (dd) “Parent” means any corporation (other than the Company) in an unbroken chain of
corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that
attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date. 
 (ee)
“Participant” means an individual or an estate or other entity that holds an Award. 
 (ff) “Performance Goals” means one
or more objective measurable performance factors as determined by the Committee with respect to each Performance Period based upon one or more factors, including, but not limited to: (i) operating income; (ii) earnings before interest,
taxes, depreciation and amortization (“EBITDA”); (iii) earnings; (iv) cash flow; (v) market share; (vi) sales or revenue; (vii) expenses; (viii) cost of goods sold; (ix) profit/loss or profit margin;
(x) working capital; (xi) return on equity or assets; (xii) earnings per share; (xiii) economic value added (“EVA”); (xiv) stock price; (xv) price/earnings ratio; (xvi) debt or debt-to-equity;
(xvii) accounts receivable; (xviii) writeoffs; (xix) cash; (xx) assets; (xxi) liquidity; (xxii) operations; (xxiii) intellectual property (e.g., patents); (xxiv) product development;
(xxv) regulatory activity, including clinical trial activity; (xxvi) manufacturing, production or inventory; (xxvii) mergers and acquisitions or divestitures; (xxviii) business development activities; (xxix) financings;
(xxx) cash burn; and/or (xxxi) cash horizon, each with respect to the Company and/or one or more of its Affiliates or operating units. Awards issued to persons who are not Covered Employees may take into account other factors. 

(gg) “Performance Period” means any period not exceeding thirty-six (36) months as determined by the Committee, in its sole discretion.
The Committee may establish different Performance Periods for different Participants, and the Committee may establish concurrent or overlapping Performance Periods. 
 (hh) “Plan” means this Targeted Genetics Corporation Stock Incentive Plan, as it may be amended from time to time. 
 (ii) “Re-Price” means that the Company has lowered or reduced the Exercise Price of outstanding Options and/or outstanding SARs for any Participant(s) in a manner described by Item 402(i)(1) of SEC
Regulation S-K (or its successor provision). 
 (jj) “Retirement” means retirement as of the individual’s normal retirement
date under the Company’s 401(k) Plan or other similar successor plan applicable to salaried employees. 
 (kk) “Rule 16b-3”
means Rule 16b-3 promulgated under the Exchange Act, as amended from time to time, or any successor provision. 
 (ll) “SAR
Agreement” means the agreement described in Section 8 evidencing each Award of a Stock Appreciation Right. 
 (mm) “SEC”
means the Securities and Exchange Commission. 
 (nn) “Section 16 Persons” means those officers, directors or other persons who are
subject to Section 16 of the Exchange Act. 
 (oo) “Securities Act” means the Securities Act of 1933, as amended. 

(pp) “Service” means the absence of any interruption or termination of service as an Employee, Director or Consultant. Continuous Service
Status shall not be considered interrupted or terminated in the case of: (i) Company approved sick leave; (ii) military leave; (iii) any other bona fide leave of absence approved by the Committee, provided that such leave is for a
period of not more than ninety (90) days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to a written Company policy. Also, Continuous Service Status as an
Employee or 
  

 6 

 
Consultant shall not be considered interrupted or terminated in the case of a transfer between locations of the Company or between the Company, its
Parents, Subsidiaries or Affiliates, or their respective successors, or a change in status from an Employee to a Consultant or from a Consultant to an Employee. 
 (qq) “Share” means one share of Common Stock. 
 (rr) “Stock Appreciation Right” or
“SAR” means a stock appreciation right awarded under the Plan. 
 (ss) “Stock Exchange” means any stock exchange or
consolidated stock price reporting system on which prices for the Common Stock are quoted at any give time. 
 (tt) “Stock Grant”
means Shares awarded under the Plan. 
 (uu) “Stock Grant Agreement” means the agreement described in Section 9 evidencing each
Award of a Stock Grant. 
 (vv) “Stock Option Agreement” means the agreement described in Section 6 evidencing each Award of an
Option. 
 (ww) “Stock Unit” means a bookkeeping entry representing the equivalent of one Share, as awarded under the Plan.

 (xx) “Stock Unit Agreement” means the agreement described in Section 10 evidencing each Award of a Stock Unit. 

(yy) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of
the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status
of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date. 
 (zz) “10-Percent
Shareholder” means an individual who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of
Section 424(d) of the Code shall be applied. 
 SECTION 3. ADMINISTRATION. 
 (a) General. The Plan shall be administered by the Board or a Committee, or a combination thereof, as determined by the Board. The Plan may be
administered by different administrative bodies with respect to different classes of Participants and, if permitted by Applicable Laws, the Board may authorize one or more officers of the Company to make Awards under the Plan to Employees and
Consultants (who are not Section 16 Persons) within parameters specified by the Board. 
 (b) Committee Composition. If a
Committee has been appointed pursuant to this Section 3, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board. From time to time the Board may increase the size of any Committee and appoint
additional members thereof, remove members (with or without cause) and appoint new members in substitution therefor, fill vacancies (however caused) and dissolve a Committee and thereafter directly administer the Plan, all to the extent permitted by
the Applicable Laws and, in the case of a Committee administering the Plan in accordance with the requirements of Rule 16b-3 or of Section 162(m) of the Code, to the extent permitted or required by such provisions. 
 Unless the Board provides otherwise, the Board’s Compensation Committee shall be the Committee. Members of the Committee shall serve for such period
of time as the Board may determine and shall be subject to removal by the Board at any time. The Board may also at any time terminate the functions of the Committee and reassume all powers and authority previously delegated to the Committee.

  

 7 

 The Committee shall have membership composition which enables (i) Awards to Section 16 Persons
to qualify as exempt from liability under Section 16(b) of the Exchange Act and (ii) Awards to Covered Employees to qualify as “performance-based compensation” as provided under Section 162(m) of the Code. 
 The Board may also appoint one or more separate committees of the Board, each composed of two or more directors of the Company who need not qualify under
Rule 16b-3 or under Section 162(m) of the Code, that may administer the Plan with respect to Key Service Providers who are not Section 16 Persons or Covered Employees, respectively, may grant Awards under the Plan to such Key Service
Providers and may determine all terms of such Awards. 
 Notwithstanding the foregoing, the Board shall constitute the Committee and shall
administer the Plan with respect to Non-Employee Directors, shall grant Awards under the Plan to such Non-Employee Directors, and shall determine all terms of such Awards. 
 (c) Authority of the Committee. Subject to the provisions of the Plan, the Committee shall have full authority and sole discretion to take any actions it deems necessary or advisable for the administration of the
Plan. Such actions shall include: 
  

	 	(i)	selecting Key Service Providers who are to receive Awards under the Plan; 

  

	 	(ii)	determining the type, number, vesting requirements and other features and conditions of such Awards and amending such Awards; 

  

	 	(iii)	correcting any defect, supplying any omission, or reconciling any inconsistency in the Plan or any Award agreement; 

  

	 	(iv)	accelerating the vesting, or extending the post-termination exercise term, of Awards at any time and under such terms and conditions as it deems appropriate;

  

	 	(v)	interpreting the Plan; 

  

	 	(vi)	making all other decisions relating to the operation of the Plan; and 

  

	 	(vii)	adopting such plans or sub-plans as may be deemed necessary or appropriate to provide for the participation by Key Service Providers of the Company and its Subsidiaries and
Affiliates who reside outside the U.S., which plans and/or sub-plans shall be attached hereto as Appendices. 

 The Committee
may adopt such rules or guidelines as it deems appropriate to implement the Plan. The Committee’s determinations under the Plan shall be final and binding on all persons. 
 (d) Indemnification. To the maximum extent permitted by applicable law, each member of the Committee, or of the Board, shall be indemnified and held
harmless by the Company against and from (i) any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may
be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan or any Stock Option Agreement, SAR Agreement, Stock Grant Agreement or Stock Unit Agreement, and (ii) from any and all amounts paid
by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such claim, action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity,
at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such
persons may be entitled under the Company’s Articles of Incorporation or Bylaws, by contract, as a matter of law, or otherwise, or under any power that the Company may have to indemnify them or hold them harmless. 
  

 8 

 SECTION 4. GENERAL. 
 (a) General Eligibility. Only Employees, Directors and Consultants shall be eligible for designation as Key Service Providers by the Committee, in its sole discretion. 
 (b) Incentive Stock Options. Only Key Service Providers who are common-law employees of the Company, a Parent or a Subsidiary shall be eligible for the
grant of ISOs. In addition, a Key Service Provider who is a 10-Percent Shareholder shall not be eligible for the grant of an ISO unless the requirements set forth in Section 422(c)(5) of the Code are satisfied. 
 (c) Restrictions on Shares. Any Shares issued pursuant to an Award shall be subject to such rights of repurchase, rights of first refusal and other
transfer restrictions as the Committee may determine, in its sole discretion. Such restrictions shall apply in addition to any restrictions that may apply to holders of Shares generally and shall also comply to the extent necessary with applicable
law. In no event shall the Company be required to issue fractional Shares under the Plan. 
 (d) Beneficiaries. Unless stated otherwise in an
Award agreement, a Participant may designate one or more beneficiaries with respect to an Award by timely filing the prescribed form with the Company. A beneficiary designation may be changed by filing the prescribed form with the Company at any
time before the Participant’s death. If no beneficiary was designated or if no designated beneficiary survives the Participant, then after a Participant’s death any vested Award(s) shall be transferred or distributed to the
Participant’s estate. 
 (e) Performance Conditions. The Committee may, in its discretion, include performance conditions in an Award. If
performance conditions are included in Awards to Covered Employees, then such Awards may be subject to the achievement of Performance Goals established by the Committee. Such Performance Goals shall be established and administered pursuant to the
requirements of Section 162(m) of the Code. Before any Shares underlying an Award or any Award payments subject to Performance Goals are released to a Covered Employee with respect to a Performance Period, the Committee shall certify in writing
that the Performance Goals for such Performance Period have been satisfied. Awards with performance conditions that are granted to Key Service Providers who are not Covered Employees need not comply with the requirements of Section 162(m) of
the Code. 
 (f) No Rights as a Shareholder. A Participant, or a transferee of a Participant, shall have no rights as a shareholder with
respect to any Common Stock covered by an Award until such person has satisfied all of the terms and conditions to receive such Common Stock, has satisfied any applicable withholding or tax obligations relating to the Award and the Shares have been
issued (as evidenced by an appropriate entry on the books of the Company or a duly authorized transfer agent of the Company). 
 (g)
Termination of Service. Unless the applicable Award agreement or, with respect to Participants who reside in the U.S., the applicable employment agreement provides otherwise, the following rules shall govern the vesting, exercisability and term of
outstanding Awards held by a Participant in the event of termination of such Participant’s Service (in all cases subject to the term of the Award as applicable): (i) upon termination of Service for any reason, all unvested portions of any
outstanding Awards shall be immediately forfeited without consideration and the vested portions of any outstanding Stock Units shall be settled; (ii) if the Service of a Participant is terminated for Cause, then all unexercised Options and
SARs, unvested portions of Stock Units and unvested portions of Stock Grants shall terminate and be forfeited immediately without consideration; (iii) if the Service of Participant is terminated for any reason other than for Cause, death,
Retirement or Disability, then the vested portion of his/her then-outstanding Options/SARs may be exercised by such Participant or his or her personal representative within three (3) months after the date of such termination; or (iv) if
the Service of a Participant is terminated due to death, Retirement or Disability, the vested portion of his/her then-outstanding Options/SARs may be exercised within twelve (12) months after the date of termination of Service. 
  

 9 

 (h) Director Fees. Subject to the consent and approval by the Board, each Non-Employee Director may elect
to receive a Stock Grant under the Plan in lieu of payment of a portion of his or her regular annual retainer based on the Fair Market Value of the Shares on the date any regular annual retainer would otherwise be paid. For purposes of the Plan, a
Non-Employee Director’s regular annual retainer shall not include any additional retainer paid in connection with service on any committee of the Board or paid for any other reason. Such an election may be for any dollar or percentage amount
equal to at least 25% of the Non-Employee Director’s regular annual retainer (up to a limit of 100% of the Non-Employee Director’s regular annual retainer). The election must be made prior to the beginning of the annual B cycle which shall
be any twelve (12) month continuous period designated by the Board. Any amount of the regular annual retainer not elected to be received as a Stock Grant shall be payable in cash in accordance with the Company’s standard payment
procedures. Shares granted under this Section 4(h) shall otherwise be subject to the terms of the Plan applicable to Non-Employee Directors or to Participants generally (other than provisions specifically applying only to Employees).

 SECTION 5. SHARES SUBJECT TO PLAN AND SHARE LIMITS. 
 (a) Basic Limitation. The stock issuable under the Plan shall be authorized but unissued Shares or Shares acquired by the Company. The aggregate number of Shares reserved for Awards under the Plan shall not exceed
4,200,000 Shares, subject to adjustment pursuant to Section 11, which includes the 950,000 Shares reserved for issuance under the Targeted Genetics Corporation 1999 Stock Option Plan immediately prior to the Plan’s approval by the Company
shareholders. All of the Shares available for issuance under the Plan may be issued as Incentive Stock Options. 
 (b) Additional Shares. If
Awards are forfeited or are terminated for any other reason before being exercised, then the Shares underlying such Awards shall again become available for Awards under the Plan. SARs shall be counted in full against the number of Shares available
for issuance under the Plan, regardless of the number of Shares issued upon settlement of the SARs. In addition, if a stock option previously granted under the Targeted Genetics Corporation 1999 Stock Option Plan terminates, expires, or lapses for
any reason, any Shares subject to such stock option shall again be available to be the subject of an Award under the Plan. 
 (c) Dividend
Equivalents. Any dividend equivalents distributed under the Plan shall not be applied against the number of Shares available for Awards. 
 (d) Share Limits. 
 (i) Limitation on Grants to Participants. Subject to adjustment as provided in Section 11
below, the maximum aggregate number of Shares that may be subject to Awards granted to any one person under the Plan for any Fiscal Year of the Company shall be 150,000 Shares, provided that such limitation shall be 500,000 Shares during the fiscal
year of any person’s initial year of service with the Company. 
 (ii) Limits on Awards to Non-Employee Directors.
Subject to adjustment pursuant to Section 11, no Non-Employee Director shall receive Awards during any Fiscal Year covering, in the aggregate, in excess of 50,000 Shares; provided that any Shares received pursuant to an election under
Section 4(h) shall not count against such limit. 
 SECTION 6. TERMS AND CONDITIONS OF OPTIONS. 
 (a) Stock Option Agreement. Each Grant of an Option under the Plan shall be evidenced and governed exclusively by a Stock Option Agreement between the
Optionee and the Company. Such Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan and that the Committee deems appropriate for
inclusion in a Stock Option Agreement (including without limitation any performance conditions). The provisions of the various Stock Option Agreements entered into under the Plan need not be identical. The Stock Option Agreement shall also specify
whether the Option is an ISO or an NSO. 
  

 10 

 (b) Number of Shares. Each Stock Option Agreement shall specify the number of Shares that are subject to
the Option and shall be subject to adjustment of such number in accordance with Section 11. 
 (c) Exercise Price. An Option’s
Exercise Price shall be established by the Committee and set forth in a Stock Option Agreement. The Exercise Price of an Option shall not be less than 100% of the Fair Market Value (110% for ISO grants to 10-Percent Shareholders) on the date of
Grant. 
 (d) Exercisability and Term. The Stock Option Agreement shall specify the term of the Option; provided that the term of an Option
shall in no event exceed ten (10) years from the date of Grant. If not so established in the instrument evidencing the Option, the Option shall vest and become exercisable according to the following schedule, which may be waived or modified by
the Committee at any time: 
  

			
	 Period of Service
	  	 Percent Vested

	After 3 months	  	6.25% of the Shares subject to the Option
		
	For each additional 3-month period thereafter	  	An additional 6.25% of the Shares subject to the Option
		
	After 4 years	  	100% of the Shares subject to the Option

 A Stock Option Agreement may provide for accelerated vesting in the event of the
Participant’s death, Disability, or other events. Notwithstanding any other provision of the Plan, no Option can be exercised after the expiration date provided in the applicable Stock Option Agreement and no Option may provide that, upon
exercise of the Option, a new Option will automatically be granted. 
 (e) Modifications or Assumption of Options. Within the limitations of
the Plan, the Committee may modify, extend or assume outstanding options or may accept the cancellation of outstanding options (whether granted by the Company or by another issuer) in return for the grant of new Options for the same or a different
number of Shares, at the same or a different Exercise Price, and with the same or different vesting provisions. Notwithstanding the preceding sentence or anything to the contrary herein, the Committee may not Re-Price outstanding Options unless
there is approval by the Company shareholders and no modification of an Option shall, without the consent of the Optionee, impair his or her rights or obligations under such Option. 
 (f) Assignment or Transfer of Options. Except as otherwise provided in the applicable Stock Option Agreement and then only to the extent permitted by
applicable law, no Option shall be transferable by the Optionee other than by will or by the laws of descent and distribution. Except as otherwise provided in the applicable Stock Option Agreement, an Option may be exercised during the lifetime of
the Optionee only by the Optionee or by the guardian or legal representative of the Optionee. No Option or interest therein may be assigned, pledged or hypothecated by the Optionee during his or her lifetime, whether by operation of law or
otherwise, or be made subject to execution, attachment or similar process. 
  

 11 

 SECTION 7. PAYMENT FOR OPTION SHARES. 
 (a) Cash. The entire Exercise Price of Shares issued upon exercise of Options shall be payable in cash at the time when such Shares are purchased.

 (b) Surrender of Stock. To the extent provided for in the applicable Stock Option Agreement, payment for all or any part of the Exercise
Price may be made with Shares which have already been owned by the Optionee; provided that the Committee may, in its sole discretion, require that Shares tendered for payment be previously held by the Optionee for a minimum duration. Such Shares
shall be valued at their Fair Market Value. 
 (c) Cashless Exercise. To the extent provided for in the applicable Stock Option Agreement,
payment for all or any part of the Exercise Price may be made through Cashless Exercise. 
 (d) Other Forms of Payment. To the extent provided
for in the applicable Stock Option Agreement, payment for all or any part of the Exercise Price may be made in any other form that is consistent with Applicable Laws, regulations and rules and approved by the Committee. 
 In the case of an ISO granted under the Plan, payment shall be made only pursuant to the express provisions of the applicable Stock Option Agreement. The
Stock Option Agreement may specify that payment may be made in any form(s) described in this Section 7. In the case of an NSO granted under the Plan, the Committee may, in its discretion at any time, accept payment in any form(s) described in
this Section 7. 
 SECTION 8. TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS. 
 (a) SAR Agreement. Each Grant of a SAR under the Plan shall be evidenced and governed exclusively by a SAR Agreement between the Participant and the
Company. Such SAR shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan and that the Committee deems appropriate for inclusion in a SAR
Agreement (including without limitation any performance conditions). A SAR Agreement may provide for a maximum limit on the amount of any payout notwithstanding the Fair Market Value on the date of exercise of the SAR. The provisions of the various
SAR Agreements entered into under the Plan need not be identical. SARs may be granted in consideration of a reduction in the Participant’s compensation. 
 (b) Number of Shares. Each SAR Agreement shall specify the number of Shares to which the SAR pertains and shall be subject to adjustment of such number in accordance with Section 11. 
 (c) Exercise Price. Each SAR Agreement shall specify the Exercise Price which shall be established by the Committee. The Exercise Price of a SAR shall not
be less than 100% of the Fair Market Value on the date of Grant. 
 (d) Exercisability and Term. The SAR Agreement shall specify the term of
the SAR which shall not exceed ten (10) years from the date of Grant. Unless the applicable SAR Agreement provides otherwise, each SAR shall vest and become exercisable with respect to 25% of the Shares subject to the SAR upon completion of one
year of Service measured from the vesting commencement date, the balance of the Shares subject to the SAR shall vest and become exercisable in thirty-six (36) equal installments upon completion of each month of Service thereafter, and the term
of the SAR shall be ten (10) years from the date of Grant. A SAR Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability, or other events. SARs may be awarded in combination with Options or Stock
Grants, and such an Award shall provide that the SARs will not be exercisable unless the related Options or Stock Grants are forfeited. A SAR may be included in an ISO only at the time of Grant but may be included in an NSO at the time of Grant or
at any subsequent time, but not later than six months before the expiration of such NSO. No SAR may provide that, upon exercise of the SAR, a new SAR will automatically be granted. 
  

 12 

 (e) Exercise of SARs. If, on the date when a SAR expires, the Exercise Price under such SAR is less than
the Fair Market Value on such date but any portion of such SAR has not been exercised or surrendered, then such SAR shall automatically be deemed to be exercised as of such date with respect to such portion. Upon exercise of a SAR, the Participant
(or any person having the right to exercise the SAR) shall receive from the Company (i) Shares, (ii) cash or (iii) any combination of Shares and cash, as the Committee shall determine at the time of Grant of the SAR, in its sole
discretion. The amount of cash and/or the Fair Market Value of Shares received upon exercise of SARs shall, in the aggregate, be equal to the amount by which the Fair Market Value (on the date of exercise) of the Shares subject to the SARs exceeds
the Exercise Price of the Shares. 
 (f) Modification or Assumption of SARs. Within the limitations of the Plan, the Committee may modify,
extend or assume outstanding stock appreciation rights or may accept the cancellation of outstanding stock appreciation rights (including stock appreciation rights granted by another issuer) in return for the grant of new SARs for the same or a
different number of Shares, at the same or a different Exercise Price, and with the same or different vesting provisions. Notwithstanding the preceding sentence or anything to the contrary herein, unless there is approval by the Company
shareholders, the Committee may not Re-Price outstanding SARs and no modification of a SAR shall, without the consent of the Participant, impair his or her rights or obligations under such SAR. 
 (g) Assignment or Transfer of SARs. Except as otherwise provided in the applicable SAR Agreement and then only to the extent permitted by applicable law,
no SAR shall be transferable by the Participant other than by will or by the laws of descent and distribution. Except as otherwise provided in the applicable SAR Agreement, a SAR may be exercised during the lifetime of the Participant only by the
Participant or by the guardian or legal representative of the Participant. No SAR or interest therein may be assigned, pledged or hypothecated by the Participant during his or her lifetime, whether by operation of law or otherwise, or be made
subject to execution, attachment or similar process. 
 SECTION 9. TERMS AND CONDITIONS FOR STOCK GRANTS. 
 (a) Amount and Form of Awards. Awards under this Section 9 may be granted in the form of a Stock Grant. Each Stock Grant Agreement shall specify the
number of Shares to which the Stock Grant pertains and shall be subject to adjustment of such number in accordance with Section 11. A Stock Grant may also be awarded in combination with NSOs, and such an Award may provide that the Stock Grant
will be forfeited in the event that the related NSOs are exercised. 
 (b) Stock Grant Agreement. Each Stock Grant awarded under the Plan
shall be evidenced and governed exclusively by a Stock Grant Agreement between the Participant and the Company. Each Stock Grant shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions
that are not inconsistent with the Plan and that the Committee deems appropriate for inclusion in the applicable Stock Grant Agreement (including without limitation any performance conditions). The provisions of the various Stock Grant Agreements
entered into under the Plan need not be identical. 
 (c) Payment for Stock Grants. Stock Grants may be issued with or without cash
consideration or any other form of legally permissible consideration approved by the Committee. 
 (d) Vesting Conditions. Each Stock Grant
may or may not be subject to vesting. Any such vesting provision may provide that Shares shall vest based on Service over time or shall vest, in full or in installments, upon satisfaction of performance conditions specified in the Stock Grant
Agreement which may include Performance Goals pursuant to Section 4(e). Unless the applicable Stock Grant Agreement provides otherwise, each Stock Grant shall vest with respect to 25% of the Shares subject to the Stock Grant upon completion of
each year of Service on each of the first through fourth annual anniversaries of the vesting commencement date. A Stock Grant Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability, or other events.

  

 13 

 (e) Assignment or Transfer of Stock Grants. Except as provided in the applicable Stock Grant Agreement,
and then only to the extent permitted by applicable law, a Stock Grant awarded under the Plan shall not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor’s process, whether voluntarily,
involuntarily or by operation of law. Any act in violation of this Section 9(e) shall be void. However, this Section 9(e) shall not preclude a Participant from designating a beneficiary who will receive any vested outstanding Stock Grant
Awards in the event of the Participant’s death, nor shall it preclude a transfer of vested Stock Grant Awards by will or by the laws of descent and distribution. 
 (f) Voting and Dividend Rights. The holder of a Stock Grant awarded under the Plan shall have the same voting, dividend and other rights as the Company’s other shareholders. A Stock Grant Agreement, however, may
require that the holder of such Stock Grant invest any cash dividends received in additional Shares subject to the Stock Grant. Such additional Shares subject to the Stock Grant shall be subject to the same conditions and restrictions as the Stock
Grant with respect to which the dividends were paid. Such additional Shares subject to the Stock Grant shall not reduce the number of Shares available for issuance under Section 5. 
 (g) Modification or Assumption of Stock Grants. Within the limitations of the Plan, the Committee may modify or assume outstanding stock grants or may
accept the cancellation of outstanding stock grants (including stock granted by another issuer) in return for the grant of new Stock Grants for the same or a different number of Shares and with the same or different vesting provisions.
Notwithstanding the preceding sentence or anything to the contrary herein, no modification of a Stock Grant shall, without the consent of the Participant, impair his or her rights or obligations under such Stock Grant. 
 SECTION 10. TERMS AND CONDITIONS OF STOCK UNITS. 
 (a) Stock Unit Agreement. Each grant of Stock Units under the Plan shall be evidenced and governed exclusively by a Stock Unit Agreement between the Participant and the Company. Such Stock Units shall be subject to
all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan and that the Committee deems appropriate for inclusion in the applicable Stock Unit Agreement (including
without limitation any performance conditions). The provisions of the various Stock Unit Agreements entered into under the Plan need not be identical. Stock Units may be granted in consideration of a reduction in the Participant’s other
compensation. 
 (b) Number of Shares. Each Stock Unit Agreement shall specify the number of Shares to which the Stock Unit Grant pertains and
shall be subject to adjustment of such number in accordance with Section 11. 
 (c) Payment for Stock Units. Stock Units shall be issued
without consideration. 
 (d) Vesting Conditions. Each Award of Stock Units may or may not be subject to vesting. Any such vesting provision
may provide that Shares shall vest based on Service over time or shall vest, in full or in installments, upon satisfaction of performance conditions specified in the Stock Unit Agreement which may include Performance Goals pursuant to
Section 4(e). Unless the applicable Stock Unit Agreement provides otherwise, each Stock Unit shall vest with respect to 25% of the Shares subject to the Stock Unit upon completion of each year of Service on each of the first through fourth
annual anniversaries of the vesting commencement date. A Stock Unit Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability, or other events. 
 (e) Voting and Dividend Rights. The holders of Stock Units shall have no voting rights. Prior to settlement or forfeiture, any Stock Unit awarded under
the Plan may, at the Committee’s discretion, carry with it a right to dividend equivalents. Such right entitles the holder to be credited with an amount equal to all cash dividends paid on one Share while the Stock Unit is outstanding. Dividend
equivalents may be 

  

 14 

 
converted into additional Stock Units. Settlement of dividend equivalents may be made in the form of cash, in the form of Shares, or in a combination of
both. Prior to distribution, any dividend equivalents which are not paid shall be subject to the same conditions and restrictions as the Stock Units to which they attach. 
 (f) Form and Time of Settlement of Stock Units. Settlement of vested Stock Units may be made in the form of (a) cash, (b) Shares or (c) any combination of both, as determined by the Committee at the
time of the grant of the Stock Units, in its sole discretion. Methods of converting Stock Units into cash may include (without limitation) a method based on the average Fair Market Value of Shares over a series of trading days. Vested Stock Units
may be settled in a lump sum or in installments. The distribution may occur or commence when the vesting conditions applicable to the Stock Units have been satisfied or have lapsed, or it may be deferred, in accordance with applicable law, to any
later date. The amount of a deferred distribution may be increased by an interest factor or by dividend equivalents. Until an Award of Stock Units is settled, the number of such Stock Units shall be subject to adjustment pursuant to Section 11.

 (g) Creditors’ Rights. A holder of Stock Units shall have no rights other than those of a general creditor of the Company. Stock Units
represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Stock Unit Agreement. 
 (h) Modification or Assumption of Stock Units. Within the limitations of the Plan, the Committee may modify or assume outstanding stock units or may accept the cancellation of outstanding stock units (including stock units granted by
another issuer) in return for the grant of new Stock Units for the same or a different number of Shares and with the same or different vesting provisions. Notwithstanding the preceding sentence or anything to the contrary herein, no modification of
a Stock Unit shall, without the consent of the Participant, impair his or her rights or obligations under such Stock Unit. 
 (i) Assignment
or Transfer of Stock Units. Except as provided in the applicable Stock Unit Agreement, and then only to the extent permitted by applicable law, Stock Units shall not be anticipated, assigned, attached, garnished, optioned, transferred or made
subject to any creditor’s process, whether voluntarily, involuntarily or by operation of law. Any act in violation of this Section 10(i) shall be void. However, this Section 10(i) shall not preclude a Participant from designating a
beneficiary who will receive any outstanding vested Stock Units in the event of the Participant’s death, nor shall it preclude a transfer of vested Stock Units by will or by the laws of descent and distribution. 
 SECTION 11. PROTECTION AGAINST DILUTION. 
 (a) Adjustments. Subject to any action required under Applicable Laws by the holders of capital stock of the Company, (i) the numbers and class of Shares or other stock or securities: (x) available for future Awards under
Section 5(a) above, (y) set forth in Section 5(d) above, and (z) covered by each outstanding Award, (ii) the Exercise Price of each outstanding Option, and (iii) any repurchase price per Share applicable to Shares
issued pursuant to any Award, shall be proportionately adjusted by the Committee in the event of a stock split, reverse stock split, stock dividend, combination, consolidation, recapitalization (including a recapitalization through a large
nonrecurring cash dividend) or reclassification of the Shares, subdivision of the Shares, a rights offering, a reorganization, merger, spin-off, split-up, change in corporate structure or other similar occurrence. Any adjustment by the Committee
pursuant to this Section 11 shall be made in the Committee’s sole and absolute discretion and shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or Exercise Price of an Award. If, by reason of a transaction described in this Section 11 or
an adjustment pursuant to this Section 11, a Participant’s Award agreement covers additional or different shares of stock or securities, then such additional or different shares, and the Award agreement in respect thereof, shall be subject
to all of the terms, conditions and restrictions which were applicable to the Award prior to such adjustment. 
  

 15 

 (b) Participant Rights. Except as provided in this Section 11, a Participant shall have no rights by
reason of any issue by the Company of stock of any class or securities convertible into stock of any class, any subdivision or consolidation of shares of stock of any class, the payment of any stock dividend or any other increase or decrease in the
number of shares of stock of any class. If by reason of an adjustment pursuant to this Section 11 a Participant’s Award covers additional or different shares of stock or securities, then such additional or different shares and the Award in
respect thereof shall be subject to all of the terms, conditions and restrictions which were applicable to the Award and the Shares subject to the Award prior to such adjustment. 
 (c) Fractional Shares. Any adjustment of Shares pursuant to this Section 11 shall be rounded down to the nearest whole number of Shares. Under no
circumstances shall the Company be required to authorize or issue fractional shares and no consideration shall be provided as a result of any fractional shares not being issued or authorized. 
 SECTION 12. EFFECT OF A CORPORATE TRANSACTION. 
 (a) Corporate Transaction. In the event that the Company is a party to a Corporate Transaction, outstanding Awards shall be subject to the applicable agreement of merger, reorganization, or sale of assets. Such agreement may provide,
without limitation, for the assumption or substitution of outstanding Options, SARs, or Stock Units by the surviving entity or its parent, for the assumption of outstanding Stock Grant Agreements by the surviving entity or its parent, for the
replacement of outstanding Options, SARs, and Stock Units with a cash incentive program of the surviving entity which preserves the spread existing on the unvested portions of such outstanding Awards at the time of the transaction and provides for
subsequent payout in accordance with the same vesting provisions applicable to those Awards, for accelerated vesting of outstanding Awards, or for the cancellation of outstanding Options, SARs, and Stock Units, with or without consideration, in all
cases without the consent of the Participant. Notwithstanding the foregoing, if outstanding Options, SARs or Stock Units are not assumed, substituted, or replaced with a cash incentive program or any outstanding Stock Grant Agreements are not
assumed pursuant to Section 12(a), then such Awards shall terminate upon the consummation of the Corporate Transaction; provided, however, that the Committee shall notify the Participant that the Award will terminate at least five (5) days
prior to the date on which the Award terminates. 
 (b) Acceleration. The Committee may determine, at the time of grant of an Award or
thereafter, that such Award shall become fully vested as to all Shares subject to such Award in the event that a Change in Control occurs. Unless otherwise provided in the applicable Award agreement, employment agreement or other applicable written
agreement, in the event that a Change in Control occurs and any outstanding Awards held by a current Key Service Provider is to be terminated (in whole or in part) pursuant to the preceding paragraph, the vesting (and exercisability, if applicable)
of each such Award shall accelerate such that the Award shall become vested (and exercisable, if applicable) in full prior to the consummation of the Change in Control at such time and on such conditions as the Committee shall determine. 

SECTION 13. LIMITATIONS ON RIGHTS. 
 (a) No
Entitlements. A Participant’s rights, if any, in respect of or in connection with any Award is derived solely from the discretionary decision of the Company to permit the individual to participate in the Plan and to benefit from a discretionary
Award. By accepting an Award under the Plan, a Participant expressly acknowledges that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards. Any Award granted hereunder is not intended to be
compensation of a continuing or recurring nature, or part of a Participant’s normal or expected compensation, and in no way represents any portion of a Participant’s salary, compensation, or other remuneration for purposes of pension
benefits, severance, redundancy, resignation or any other purpose. 
  

 16 

 Neither the Plan nor any Award granted under the Plan shall be deemed to give any individual a right to
remain an Employee, Consultant or Director of the Company, a Parent, a Subsidiary or an Affiliate. The Company and its Parent and Subsidiaries and Affiliates reserve the right to terminate the Service of any person at any time, and for any reason,
subject to Applicable Laws, the Company’s Articles of Incorporation and Bylaws and a written employment agreement (if any), and such terminated person shall be deemed irrevocably to have waived any claim to damages or specific performance for
breach of contract or dismissal, compensation for loss of office, tort or otherwise with respect to the Plan or any outstanding Award that is forfeited and/or is terminated by its terms or to any future Award. 
 (b) Shareholders’ Rights. A Participant shall have no dividend rights, voting rights or other rights as a shareholder with respect to any Shares
covered by his or her Award prior to the issuance of such Shares (as evidenced by an appropriate entry on the books of the Company or a duly authorized transfer agent of the Company). No adjustment shall be made for cash dividends or other rights
for which the record date is prior to the date when such Shares are issued, except as expressly provided in Section 11. 
 (c) Issuance
Requirements. Any other provision of the Plan notwithstanding, the obligation of the Company to issue Shares or other securities under the Plan shall be subject to all Applicable Laws, rules and regulations and such approval by any regulatory body
as may be required. The Company reserves the right to restrict, in whole or in part, the delivery of Shares or other securities pursuant to any Award prior to the satisfaction of all legal requirements relating to the issuance of such Shares or
other securities, to their registration, qualification or listing or to an exemption from registration, qualification or listing. 
 SECTION 14.
WITHHOLDING TAXES. 
 (a) General. A Participant shall make arrangements satisfactory to the Company for the satisfaction of
any withholding tax obligations that arise in connection with his or her Award. The Company shall not be required to issue any Shares or make any cash payment under the Plan until such obligations are satisfied. 
 (b) Share Withholding. If a public market for the Company’s Shares exists, the Committee may permit a Participant to satisfy all or part of his or
her withholding or income tax obligations by having the Company withhold all or a portion of any Shares that otherwise would be issued to him or her or by surrendering or attesting to all or a portion of any Shares that he or she previously
acquired. Such Shares shall be valued based on the value of the actual trade or, if there is none, the Fair Market Value as of the previous day. Any payment of taxes by assigning Shares to the Company may be subject to restrictions, including, but
not limited to, any restrictions required by rules of the SEC. The Committee may, in its discretion, also permit a Participant to satisfy withholding or income tax obligations related to an Award through Cashless Exercise or through a sale of Shares
underlying the Award. 
 SECTION 15. DURATION AND AMENDMENTS. 
 (a) Term of the Plan. The Plan shall become effective upon its adoption by the Board. It shall continue in effect for a term of ten (10) years unless
sooner terminated under this Section 15. If required by the Applicable Laws, continuance of the Plan shall be subject to approval by the holders of capital stock of the Company within twelve (12) months before or after the date the Plan is
adopted or, to the extent required by Applicable Laws, any date the Plan is amended. Such approval shall be obtained in the manner and to the degree required under the Applicable Laws. 
 (b) Right to Amend or Terminate the Plan. The Board may amend or terminate the Plan at any time and for any reason. The termination of the Plan, or any
amendment thereof, shall not impair the rights or obligations of any Participant under any Award previously granted under the Plan without the Participant’s consent. No Awards shall be granted under the Plan after the Plan’s termination.
An amendment of the Plan shall be subject to the approval of the Company’s shareholders only to the extent such approval is otherwise required by Applicable Laws, regulations or rules. 
  

 17 

 SECTION 16. ADDENDA. 
 The Committee may approve such addenda to the Plan as it may consider necessary or appropriate for the purpose of granting Awards to Employees, Consultants or Directors, which Awards may contain such terms and
conditions as the Committee deems necessary or appropriate to accommodate differences in local law, tax policy or custom, which, if so required under Applicable Laws, may deviate from the terms and conditions set forth in the Plan. The terms of any
such addenda shall supersede the terms of the Plan to the extent necessary to accommodate such differences but shall not otherwise affect the terms of the Plan as in effect for any other purpose. 
 SECTION 17. SEVERABILITY. 
 If any provision of
the Plan or any Award is determined to be invalid, illegal or unenforceable in any jurisdiction, or as to any person, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or
deemed amended to conform to Applicable Laws, or, if it cannot be so construed or deemed amended without, in the Committee’s determination, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such
jurisdiction, person or Award, and the remainder of the Plan and any such Award shall remain in full force and effect. 
 SECTION 18.
EXECUTION. 
 To record the adoption of the Plan by the Board, the Company has caused its duly authorized officer to execute
the Plan on behalf of the Company. 
  

			
	TARGETED GENETICS CORPORATION
		
	By	 	 /s/    David J. Poston

	Title	 	Vice President, Finance and Chief Financial Officer

  

 18Form of Thirty-Ninth Supplemental Indenture

 Exhibit 4.3 
 DOMINION RESOURCES, INC. 
 Issuer 
 AND 
 DEUTSCHE BANK TRUST COMPANY AMERICAS 
 Series Trustee 
  
  
 Thirty-Ninth Supplemental
Indenture 
 Dated as of August 1, 2009 
  
  
 $500,000,000 
 2009 Series A 5.20% Senior Notes 
 due 2019

 TABLE OF CONTENTS* 
 ARTICLE I 
 2009 SERIES A 5.20% 
 SENIOR NOTES DUE 2019 
  

					
	SECTION 101.	  	Establishment	  	2
	SECTION 102.	  	Definitions	  	2
	SECTION 103.	  	Payment of Principal and Interest	  	5
	SECTION 104.	  	Denominations	  	6
	SECTION 105.	  	Global Securities	  	6
	SECTION 106.	  	Redemption	  	7
	SECTION 107.	  	Sinking Fund	  	7
	SECTION 108.	  	Additional Interest	  	7
	SECTION 109.	  	Paying Agent	  	7
	SECTION 110.	  	Limitation on Liens	  	7
			
		  	ARTICLE II	  	
		  	THE SERIES TRUSTEE	  	
			
	SECTION 201.	  	Appointment of Series Trustee	  	10
	SECTION 202.	  	Eligibility of Series Trustee	  	10
	SECTION 203.	  	Security Registrar and Paying Agent	  	10
	SECTION 204.	  	Concerning the Trustees	  	11
	SECTION 205.	  	Patriot Act Requirements of Series Trustee	  	11
			
		  	ARTICLE III	  	
		  	MISCELLANEOUS PROVISIONS	  	
			
	SECTION 301.	  	Recitals by Company	  	11
	SECTION 302.	  	Ratification and Incorporation of Base Indenture	  	11
	SECTION 303.	  	Executed in Counterparts	  	12
	SECTION 304.	  	Assignment	  	12

  

	*	This Table of Contents does not constitute part of the Indenture or have any bearing upon the interpretation of any of its terms and provisions 

 THIS THIRTY-NINTH SUPPLEMENTAL INDENTURE is made as of the first day of August, 2009,
by and between DOMINION RESOURCES, INC., a Virginia corporation, having its principal office at 120 Tredegar Street, Richmond, Virginia 23219 (the “Company”), and DEUTSCHE BANK TRUST COMPANY AMERICAS, a New York banking corporation, as
Trustee of the series of Securities established by this Thirty-Ninth Supplemental Indenture, having a corporate trust office at 60 Wall Street, 27th Floor, New York, New York 10005 (herein called the “Series Trustee”). 
 W I T N E S S E T H: 
 WHEREAS, the Company
has heretofore entered into an Indenture dated as of June 1, 2000, between the Company and The Bank of New York Mellon (successor to JPMorgan Chase Bank, N.A. (formerly known as The Chase Manhattan Bank)) (the “Original Trustee”), as
amended by the Thirty-Eighth Supplemental and Amending Indenture dated as of November 1, 2008 (as so amended, the “Base Indenture”), by and among the Company, the Original Trustee and the Series Trustee; 
 WHEREAS, the Base Indenture is incorporated herein by this reference and the Base Indenture, as heretofore supplemented, as further supplemented by this
Thirty-Ninth Supplemental Indenture, and as may be hereafter supplemented or amended from time to time, is herein called the “Indenture”; 
 WHEREAS, under the Base Indenture, a new series of Securities may at any time be established in accordance with the provisions of the Base Indenture and the terms of such series may be described by a supplemental indenture executed by the
Company and the Series Trustee; 
 WHEREAS, the Company proposes to create under the Indenture a new series of Securities and to appoint the
Series Trustee as Trustee under the Base Indenture with respect to such series of Securities; 
 WHEREAS, additional Securities of other
series hereafter established, except as may be limited in the Base Indenture as at the time supplemented and modified, may be issued from time to time pursuant to the Indenture as at the time supplemented and modified; and the Original Trustee will,
unless and until a Person other than the Original Trustee is appointed to act as Trustee with respect to the Securities of such series, serve as Trustee of such series; 
 WHEREAS, all conditions necessary to authorize the execution and delivery of this Thirty-Ninth Supplemental Indenture and to make it a valid and binding obligation of the Company have been done or performed.

 NOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the
sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: 

 ARTICLE I 
 2009 SERIES A 5.20% SENIOR NOTES DUE 2019 
 SECTION 101. Establishment. There is hereby
established a new series of Securities to be issued under the Indenture, to be designated as the Company’s 2009 Series A 5.20% Senior Notes due 2019 (the “Series A Senior Notes”). 
 There are to be authenticated and delivered $500,000,000 principal amount of Series A Senior Notes, and such principal amount of the Series A Senior
Notes may be increased from time to time pursuant to Section 301(2) of the Indenture. All Series A Senior Notes need not be issued at the same time and such series may be reopened at any time, without the consent of any Holder, for issuances of
additional Series A Senior Notes. Any such additional Series A Notes will have the same interest rate, maturity and other terms as those initially issued. Further Series A Senior Notes may also be authenticated and delivered as provided by Sections
304, 305, 306, 905 or 1107 of the Base Indenture. 
 The Series A Senior Notes shall be issued in definitive fully registered form without
coupons, in substantially the form set out in Exhibit A hereto. The entire initially issued principal amount of the Series A Senior Notes shall initially be evidenced by one or more certificates issued to Cede & Co., as nominee for
The Depository Trust Company. 
 The form of the Series Trustee’s Certificate of Authentication for the Series A Senior Notes shall be
in substantially the form set forth in Exhibit B hereto. 
 Each Series A Senior Note shall be dated the date of authentication
thereof and shall bear interest from the date of original issuance thereof or from the most recent Interest Payment Date to which interest has been paid or duly provided for. 
 SECTION 102. Definitions. The following defined terms used herein shall, unless the context otherwise requires, have the meanings specified below.
Capitalized terms used herein for which no definition is provided herein shall have the meanings set forth in the Base Indenture. 
 “Adjusted Treasury Rate” means, with respect to any Redemption Date: (i) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical
release designated “H.15(519)” or any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to
constant maturity under the caption “Treasury Constant Maturities,” for the maturity corresponding to the Comparable Treasury Issue (if no maturity is within three months before or after the Remaining Life, yields for the two published
maturities most closely corresponding to the Comparable Treasury Issue will be determined and the Adjusted Treasury Rate will be interpolated or extrapolated from such yields on a straight line basis, rounding to the nearest month); or (ii) if
such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue,
calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date. 
  

 2 

 “Business Day” means a day other than (i) a Saturday or a Sunday, (ii) a day on which
banks in New York, New York are authorized or obligated by law or executive order to remain closed or (iii) a day on which the Corporate Trust Office of the Series Trustee is closed for business. 
 “Comparable Treasury Issue” means the United States Treasury security selected by an Independent Investment Banker as having a maturity
comparable to the remaining term of the Series A Senior Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable
maturity to the Remaining Life. 
 “Comparable Treasury Price” for any Redemption Date means (i) the average of the Reference
Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (ii) if the Independent Investment Banker obtains fewer than five such Reference Treasury Dealer Quotations,
the average of all such quotations. 
 “Corporate Trust Office of the Series Trustee” means the office of the
Series Trustee at which at any particular time its corporate trust business with respect to the series of Securities herein described shall be principally administered, which office at the date of original execution of this Thirty-Ninth Supplemental
Indenture is located at 60 Wall Street, 27th Floor, New York, New York 10005 (in
addition copies of correspondence are to be sent to Deutsche Bank National Trust Company for Deutsche Bank Trust Company Americas, 25 DeForst Avenue, Mail Stop 0105, Summit, New Jersey, 07901). 
 “Independent Investment Banker” means any of BNP Paribas Securities Corp., Deutsche Bank Securities Inc., J. P. Morgan Securities Inc. or
Morgan Stanley & Co. Incorporated, and their respective successors as selected by the Company, or if any such firm is unwilling or unable to serve as such, an independent investment and banking institution of national standing appointed by
the Company. 
 “Interest Payment Dates” means February 15 and August 15 of each year, commencing on February 15,
2010. 
 “Lien” means any mortgage, lien, pledge, security interest or other encumbrance of any kind. 
 “Material Subsidiary” means a Subsidiary of the Company whose total assets (as determined in accordance with GAAP) represent at least 20% of
the total assets of the Company on a consolidated basis. 
 “Original Issue Date” means August 14, 2009. 
 “Outstanding”, when used with respect to the Series A Senior Notes, means, as of the date of determination, all Series A Senior Notes,
theretofore authenticated and delivered under the Indenture, except: 
 (i) Series A Senior Notes theretofore canceled by the Series Trustee
or delivered to the Series Trustee for cancellation; 
  

 3 

 (ii) Series A Senior Notes for whose payment at Maturity the necessary amount of money or money’s
worth has been theretofore deposited (other than pursuant to Section 402 of the Base Indenture) with the Series Trustee or any Paying Agent (other than the Company) in trust or set aside and segregated in trust by the Company (if the Company
shall act as its own Paying Agent) for the Holders of such Series A Senior Notes; 
 (iii) Series A Senior Notes with respect to which the
Company has effected defeasance or covenant defeasance has been effected pursuant to Section 402 of the Base Indenture; and 
 (iv)
Series A Senior Notes that have been paid pursuant to Section 306 of the Base Indenture or in exchange for or in lieu of which other Series A Senior Notes have been authenticated and delivered pursuant to the Indenture, other than any such
Series A Senior Notes in respect of which there shall have been presented to the Series Trustee proof satisfactory to it that such Series A Senior Notes are held by a bona fide purchaser in whose hands such Series A Senior Notes are valid
obligations of the Company; provided, however, that in determining whether the Holders of the requisite principal amount of Outstanding Series A Senior Notes have given any request, demand, authorization, direction, notice, consent or waiver
hereunder or are present at a meeting of Holders of Series A Senior Notes for quorum purposes, Series A Senior Notes owned by the Company or any other obligor upon the Series A Senior Notes or any Affiliate of the Company or such other obligor shall
be disregarded and deemed not to be Outstanding, except that, in determining whether the Series Trustee shall be protected in making any such determination or relying upon any such request, demand, authorization, direction, notice, consent or
waiver, only Series A Senior Notes which the Series Trustee actually knows to be so owned shall be so disregarded. Series A Senior Notes so owned which shall have been pledged in good faith may be regarded as Outstanding if the pledgee establishes
to the satisfaction of the Series Trustee (A) the pledgee’s right so to act with respect to such Series A Senior Notes and (B) that the pledgee is not the Company or any other obligor upon the Series A Senior Notes or an Affiliate of
the Company or such other obligor. 
 “Principal Property” means any plant or facility of the Company located in the United States
that in the opinion of the Board of Directors or management of the Company is of material importance to the business conducted by the Company and its consolidated Subsidiaries taken as whole. 
 “Reference Treasury Dealer” means: (i) BNP Paribas Securities Corp., Deutsche Bank Securities Inc., J. P. Morgan Securities Inc. or Morgan
Stanley & Co. Incorporated and their respective successors; provided that, if any such firm or its successors ceases to be a primary U.S. Government securities dealer in the United States (a “Primary Treasury Dealer”), the Company
shall substitute another Primary Treasury Dealer; and (ii) up to one other Primary Treasury Dealer selected by the Company. 
 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable
Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker at 5:00 p.m., New York City time, on the third Business Day preceding such Redemption Date. 
  

 4 

 “Regular Record Date” means, with respect to each Interest Payment Date, the close of business
on the Business Day preceding such Interest Payment Date; provided, that with respect to Series A Senior Notes that are not represented by one or more Global Securities, the Regular Record Date shall be the close of business on the 15th
calendar day (whether or not a Business Day) preceding such Interest Payment Date. 
 “Remaining Life” means the remaining term of
the Series A Senior Notes. 
 “Stated Maturity” means August 15, 2019. 
 The terms “Company,” “Original Trustee,” “Series Trustee,” “Base Indenture,” and “Indenture” shall have
the respective meanings set forth in the recitals to this Thirty-Ninth Supplemental Indenture and the paragraph preceding such recitals. 
 SECTION 103. Payment of Principal and Interest. The principal of the Series A Senior Notes shall be due at the Stated Maturity (unless earlier redeemed). The unpaid principal amount of the Series A Senior Notes shall bear interest at
the rate of 5.20% per annum until paid or duly provided for, such interest to accrue from the Original Issue Date or from the most recent Interest Payment Date to which interest has been paid or duly provided for. Interest shall be paid
semi-annually in arrears on each Interest Payment Date to the Person in whose name the Series A Senior Notes are registered on the Regular Record Date for such Interest Payment Date; provided that interest payable at the Stated Maturity of
principal, on a Redemption Date or a Repayment Date as provided herein will be paid to the Person to whom principal is payable. Any such interest that is not so punctually paid or duly provided for will forthwith cease to be payable to the Holders
on such Regular Record Date and may either be paid to the Person or Persons in whose name the Series A Senior Notes are registered at the close of business on a Special Record Date for the payment of such defaulted interest to be fixed by the Series
Trustee (in accordance with Section 307 of the Base Indenture), notice whereof shall be given to Holders of the Series A Senior Notes not less than ten (10) days prior to such Special Record Date, or be paid at any time in any other lawful
manner not inconsistent with the requirements of any securities exchange, if any, on which the Series A Senior Notes may be listed, and upon such notice as may be required by any such exchange, all as more fully provided in the Base Indenture.

 Payments of interest on the Series A Senior Notes will include interest accrued to but excluding the respective Interest Payment Dates.
Interest payments for the Series A Senior Notes shall be computed and paid on the basis of a 360-day year of twelve 30-day months. In the event that any date on which interest is payable on the Series A Senior Notes is not a Business Day, then
payment of the interest payable on such date will be made on the next succeeding day that is a Business Day (and without any interest or payment in respect of any such delay), in each case with the same force and effect as if made on the date the
payment was originally payable. 
 Payment of the principal and interest on the Series A Senior Notes shall be made at the office of the
Paying Agent in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts, with any such payment 

  

 5 

 
that is due at the Stated Maturity of any Series A Senior Notes, upon redemption or repurchase being made upon surrender of such Series A Senior Notes to the
Paying Agent. Payments of interest (including interest on any Interest Payment Date) will be made, subject to such surrender where applicable, at the option of the Company, (i) by check mailed to the address of the Person entitled thereto as
such address shall appear in the Security Register or (ii) by wire transfer at such place and to such account at a banking institution in the United States as may be designated in writing to the Series Trustee at least sixteen (16) days
prior to the date for payment by the Person entitled thereto. In the event that any date on which principal and interest is payable on the Series A Senior Notes is not a Business Day, then payment of the principal and interest payable on such date
will be made on the next succeeding day that is a Business Day (and without any interest or payment in respect of any such delay), in each case with the same force and effect as if made on the date the payment was originally payable. 
 SECTION 104. Denominations. The Series A Senior Notes may be issued in denominations of $1,000, or any greater integral multiple of $1,000.

 SECTION 105. Global Securities. The Series A Senior Notes will be issued initially in the form of one or more Global Securities
registered in the name of the Depositary (which shall be The Depository Trust Company) or its nominee. Except under the limited circumstances described below, Series A Senior Notes represented by such Global Securities will not be exchangeable for,
and will not otherwise be issuable as, Series A Senior Notes in definitive form. The Global Securities described above may not be transferred except by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary
or another nominee of the Depositary or to a successor Depositary or its nominee. 
 Owners of beneficial interests in such a Global Security
will not be considered the Holders thereof for any purpose under the Indenture, and no Global Security representing a Series A Senior Note shall be exchangeable, except for another Global Security of like denomination and tenor to be registered in
the name of the Depositary or its nominee or to a successor Depositary or its nominee or except as described below. The rights of Holders of such Global Security shall be exercised only through the Depositary. 
 A Global Security shall be exchangeable for Series A Senior Notes registered in the names of persons other than the Depositary or its nominee only if
(i) the Depositary notifies the Company that it is unwilling or unable to continue as a Depositary for such Global Security and no successor Depositary shall have been appointed by the Company within 90 days of receipt by the Company of such
notification, or if at any time the Depositary ceases to be a clearing agency registered under the Exchange Act at a time when the Depositary is required to be so registered to act as such Depositary and no successor Depositary shall have been
appointed by the Company within 90 days after it becomes aware of such cessation, or (ii) the Company in its sole discretion determines that such Global Security shall be so exchangeable, in which case Series A Senior Notes in definitive form
will be printed and delivered to the Depositary. Any Global Security that is exchangeable pursuant to the preceding sentence shall be exchangeable for Series A Senior Notes registered in such names as the Depositary shall direct. 
  

 6 

 SECTION 106. Redemption. The Series A Senior Notes are redeemable, in whole or in part, at any
time, and at the option of the Company, at a Redemption Price equal to the greater of: 
 (i) 100% of the principal amount of Series A Senior
Notes then Outstanding to be so redeemed, or 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest thereon (not including any portion of such payments of interest accrued as of the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Adjusted
Treasury Rate, plus 25 basis points, as calculated by an Independent Investment Banker, 
 plus, in either of the above cases, accrued and unpaid interest
thereon to the Redemption Date. 
 Unless the Company defaults in the payment of the Redemption Price, on and after the Redemption Date,
interest will cease to accrue on the Series A Senior Notes or portions thereof called for redemption. 
 The Adjusted Treasury Rate shall be
calculated on the third Business Day preceding the Redemption Date. 
 In the event of the redemption of the Series A Senior Notes in part
only, a new Series A Senior Note or Notes for the unredeemed portion will be issued in the name or names of the Holders thereof upon surrender thereof. 
 The Company shall notify the Series Trustee of the Redemption Price promptly after the calculation thereof and the Series Trustee shall have no responsibility for such calculation. 
 SECTION 107. Sinking Fund. The Series A Senior Notes shall not have a sinking fund. 
 SECTION 108. Additional Interest. Any principal of and installment of interest on the Series A Senior Notes that is overdue shall bear interest at
the rate of 5.20% (to the extent that the payment of such interest shall be legally enforceable), from the dates such amounts are due until they are paid or made available for payment, and such interest shall be payable on demand. 
 SECTION 109. Paying Agent. The Series Trustee shall initially serve as Paying Agent with respect to the Series A Senior Notes, with the Place of
Payment initially being the Corporate Trust Office of the Series Trustee. 
 SECTION 110. Limitation on Liens. The Company will not,
while any of the Series A Senior Notes remain Outstanding, create, or suffer to be created or to exist, any Lien upon any Principal Property of the Company or upon any shares of stock of any Material Subsidiary of the Company, whether such Principal
Property is, or shares of stock are, now owned or hereafter acquired, to secure any indebtedness for borrowed money of the Company, 
  

 7 

 unless it shall make effective provision whereby the Series A Senior Notes then Outstanding shall be secured by such Lien
equally and ratably with any and all indebtedness for borrowed money thereby secured so long as any such indebtedness shall be so secured; provided, however, that nothing in this Section shall be construed to prevent the Company from creating, or
from suffering to be created or to exist, any Liens, or any agreements, with respect to: 
  

	 	(1)	purchase money mortgages, or other purchase money liens, pledges, security interests or encumbrances of any kind upon property hereafter acquired by the Company, or Liens of any
kind existing on any property or any shares of stock at the time of the acquisition thereof (including Liens which exist on any property or any shares of stock of a Person which is consolidated with or merged with or into the Company or which
transfers or leases all or substantially all of its properties to the Company), or conditional sales agreements or other title retention agreements and leases in the nature of title retention agreements with respect to any property hereafter
acquired; provided, however, that no such Lien shall extend to or cover any other property of the Company; 

  

	 	(2)	 Liens upon any property of the Company or any shares of stock of any Material Subsidiary of the Company existing as of the date of the initial issuance of the
Series A Senior Notes or upon the shares of stock of any corporation, which Liens existed at the time such corporation became a Material Subsidiary of the Company; liens for taxes or assessments or other governmental charges or levies; pledges to
secure other governmental charges or levies; pledges or deposits to secure obligations under worker’s compensation laws, unemployment insurance and other social security legislation, including liens of judgments thereunder which are not
currently dischargeable; pledges or deposits to secure performance in connection with bids, tenders, contracts (other than contracts for the payment of money) or leases to which the Company is a party; pledges or deposits to secure public or
statutory obligations of the Company; builders’, materialmen’s, mechanics’, carriers’, warehousemen’s, workers’, repairmen’s, operators’, landlords’ or other like liens in the ordinary course of business,
or deposits to obtain the release of such liens; pledges or deposits to secure, or in lieu of, surety, stay, appeal, indemnity, customs, performance or return-of-money bonds; other pledges or deposits for similar purposes in the ordinary course of
business; liens created by or resulting from any litigation or proceeding which at the time is being contested in good faith by appropriate proceedings; liens incurred in connection with the issuance of bankers’ acceptances and lines of credit,
bankers’ liens or rights of offset and any security given in the ordinary course of business to banks or others to secure any indebtedness payable on demand or maturing within 12 months of the date that such indebtedness is originally incurred;
liens incurred in connection with repurchase, swap or other similar agreements (including, without limitation, commodity price, currency exchange and interest rate protection agreements); leases made, or existing on property acquired, in the
ordinary course of business; liens securing industrial revenue or pollution control bonds; liens, pledges, security interests or other encumbrances on any property arising in connection with any defeasance, covenant defeasance or in-substance
defeasance of indebtedness of the Company, including the Series A Senior Notes; 

  

 8 

	 	 
liens created in connection with, and created to secure, a non-recourse obligation; zoning restrictions, easements, licenses, rights-of-way, restrictions on
the use of property or minor irregularities in title thereto, which do not, in the opinion of the Company, materially impair the use of such property in the operation of the business of the Company or the value of such property for the purpose of
such business; 

  

	 	(3)	Liens in favor of the United States, any foreign country or any department, agency or instrumentality or political subdivision of any such jurisdiction, to secure partial, progress,
advance or other payments pursuant to any contract or statute or to secure any indebtedness incurred for the purpose of financing all or any part of the purchase price or the cost of constructing or improving the property subject to such mortgages,
including, without limitation, mortgages to secure indebtedness of the pollution control or industrial revenue bond type; 

  

	 	(4)	indebtedness which may be issued by the Company in connection with a consolidation or merger of the Company or any Material Subsidiary of the Company with or into any other Person
(which may be an Affiliate of the Company or any Material Subsidiary of the Company) in exchange for or otherwise in substitution for secured indebtedness of such Person (“Third Party Debt”) which by its terms (i) is secured by a
mortgage on all or a portion of the property of such Person, (ii) prohibits secured indebtedness from being incurred by such Person, unless the Third Party Debt shall be secured equally and ratably with such secured indebtedness or
(iii) prohibits secured indebtedness from being incurred by such Person; 

  

	 	(5)	indebtedness of any Person which is required to be assumed by the Company in connection with a consolidation or merger of such Person, with respect to which any property of the
Company is subjected to a Lien; 

  

	 	(6)	Liens of any kind upon any property acquired, constructed, developed or improved by the Company (whether alone or in association with others) after the date of the initial issuance
of the Series A Senior Notes which are created prior to, at the time of, or within 18 months after such acquisition (or in the case of property constructed, developed or improved, after the completion of such construction, development or improvement
and commencement of full commercial operation of such property, whichever is later) to secure or provide for the payment of any part of the purchase price or cost thereof; provided that in the case of such construction, development or improvement
the Liens shall not apply to any property theretofore owned by the Company other than theretofore unimproved real property; 

  

	 	(7)	Liens in favor of the Company, one or more Material Subsidiaries of the Company, one or more wholly-owned Subsidiaries of the Company or any of the foregoing in combination;

  

	 	(8)	 the replacement, extension or renewal (or successive replacements, extensions or 

  

 9 

	 	 
renewals), as a whole or in part, of any Lien, or of any agreement, referred to above in clauses (1) through (7) inclusive, or the replacement,
extension or renewal (not exceeding the principal amount of indebtedness secured thereby together with any premium, interest, fee or expense payable in connection with any such replacement, extension or renewal) of the indebtedness secured thereby;
provided that such replacement, extension or renewal is limited to all or a part of the same property that secured the Lien replaced, extended or renewed (plus improvements thereon or additions or accessions thereto); or

  

	 	(9)	any other Lien not excepted by the foregoing clauses (1) through (8); provided that immediately after the creation or assumption of such Lien, the aggregate principal amount of
indebtedness for borrowed money of the Company secured by all Liens created or assumed under the provisions of this clause (9) shall not exceed an amount equal to 10% of the common shareholders’ equity of the Company, as shown on its
consolidated balance sheet for the accounting period occurring immediately prior to the creation or assumption of such Lien. 

 This Section 110 has been included in this Thirty-Ninth Supplemental Indenture expressly and solely for the benefit of the Series A Senior Notes and shall be subject to covenant defeasance pursuant to Section 402(3) of the Base
Indenture. 
 ARTICLE II 
 THE SERIES TRUSTEE 
 SECTION 201. Appointment of Series Trustee. Pursuant to the Base Indenture and pursuant to this
Thirty-Ninth Supplemental Indenture, the Company hereby appoints the Series Trustee as Trustee under the Base Indenture with respect to the Series A Senior Notes, and by execution hereof the Series Trustee accepts such appointment. Pursuant to the
Base Indenture, all the rights, powers, trusts and duties of the Original Trustee under the Base Indenture shall be vested in the Series Trustee with respect to the Series A Senior Notes, there shall continue to be vested in the Original Trustee all
of its rights, powers, trusts and duties as Trustee under the Base Indenture with respect to all of the series of Securities as to which it has served and continues to serve as Trustee, and the Original Trustee shall have no rights, powers, trusts
and duties with respect to the Series A Senior Notes. 
 SECTION 202. Eligibility of Series Trustee. The Series Trustee hereby
represents that it is qualified and eligible under the provisions of the Trust Indenture Act and Section 608 of the Base Indenture and the provisions of the Trust Indenture Act to accept its appointment as Trustee with respect to the Series A
Senior Notes under the Base Indenture and hereby accepts the appointment as such Trustee. 
 SECTION 203. Security Registrar and Paying
Agent. Pursuant to the Base Indenture, the Company hereby appoints Deutsche Bank Trust Company Americas as “Security Registrar” and “Paying Agent” with respect to the Series A Senior Notes. 
  

 10 

 SECTION 204. Concerning the Trustees. Neither the Original Trustee nor the Series Trustee assumes
any duties, responsibilities or liabilities by reason of this Thirty-Ninth Supplemental Indenture other than as set forth in the Base Indenture and, in carrying out its responsibilities hereunder, each shall have all of the rights, powers,
privileges, protections, duties and immunities which it possesses under the Base Indenture. The Original Trustee and the Series Trustee shall not constitute co-trustees of the same trust, and each of the Original Trustee and the Series Trustee shall
be trustee of a trust or trusts under the Indenture separate and apart from any trust or trusts under the Indenture administered by the other trustee. The Original Trustee shall have no liability for any acts or omissions of the Series Trustee and
the Series Trustee shall have no liability for any acts or omissions of the Original Trustee. 
 References in this Thirty-Ninth Supplemental
Indenture to sections of the Base Indenture that require or permit actions by the Original Trustee with respect to Securities of the series established hereby shall be deemed to require or permit actions only by the Series Trustee and the Original
Trustee shall have no responsibility therefor. 
 SECTION 205. Patriot Act Requirements of Series Trustee. To help the United States
government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account or establishes a relationship. For
a non-individual person such as a business entity, a charity, a trust, or other legal entity, the Series Trustee will ask for documentation to verify such non-individual person’s formation and existence as a legal entity. The Series Trustee may
also seek to see financial statements, licenses, identification and authorization documents from individuals claiming authority to represent the entity or other relevant documentation. 
 ARTICLE III 
 MISCELLANEOUS PROVISIONS 
 SECTION 301. Recitals by Company. The recitals in this Thirty-Ninth Supplemental Indenture are made by the Company only and not by the Original
Trustee or the Series Trustee, and all of the provisions contained in the Base Indenture in respect of the rights, powers, privileges, protections, duties and immunities of the Original Trustee shall be applicable, but only to the Series Trustee in
respect of the Series A Senior Notes and of this Thirty-Ninth Supplemental Indenture (to the extent relating to the Series A Senior Notes) as fully and with like effect as if set forth herein in full. 
 SECTION 302. Ratification and Incorporation of Base Indenture. As supplemented hereby, the Base Indenture is in all respects ratified and
confirmed by the Company and, with respect to the Securities for which the Series Trustee has been appointed as Trustee, including the Series A Senior Notes, by the Series Trustee. The Base Indenture and this Thirty-Ninth Supplemental Indenture
shall be read, taken and construed as one and the same instrument. 
  

 11 

 SECTION 303. Executed in Counterparts. This Thirty-Ninth Supplemental Indenture may be executed in
several counterparts, each of which shall be deemed to be an original, and such counterparts shall together constitute but one and the same instrument. 
 SECTION 304. Assignment. The Company shall have the right at all times to assign any of its rights or obligations under the Indenture with respect to the Series A Senior Notes to a direct or indirect
wholly-owned subsidiary of the Company; provided that, in the event of any such assignment, the Company shall remain primarily liable for the performance of all such obligations. The Indenture may also be assigned by the Company in connection with a
transaction described in Article Eight of the Base Indenture. 
  

 12 

 IN WITNESS WHEREOF, each party hereto has caused this instrument to be signed in its name and behalf by
its duly authorized officer, all as of the day and year first above written. 
  

			
	DOMINION RESOURCES, INC.
		
	By:	 	  

	Name:	 	James P. Carney
	Title:	 	Vice President and Assistant Treasurer
	
	 DEUTSCHE BANK TRUST COMPANY
 AMERICAS, as
Series Trustee

		
	By:	 	  

	Name:	 	
	Title:	 	
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 13 

 EXHIBIT A 
 FORM OF 
 2009 SERIES A 5.20% SENIOR NOTE 
 DUE 2019 
 [UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK, NEW YORK) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
[CEDE & CO.] OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY AND ANY PAYMENT IS MADE TO [CEDE & CO.], ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, [CEDE & CO.], HAS AN INTEREST HEREIN.]** 
 [THIS SERIES A SENIOR NOTE IS A
GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF. THIS SERIES A SENIOR NOTE MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO
TRANSFER OF THIS SERIES A SENIOR NOTE IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE.]** 
  
  
 DOMINION RESOURCES, INC. 
  
  
 $         
 2009 SERIES A 5.20% SENIOR NOTE 
 DUE 2019 
  

			
	No. R-	 	CUSIP No. 25746U BH1

 Dominion Resources, Inc., a corporation duly organized and existing under the laws of Virginia
(herein called the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to [Cede & Co.]**, or registered assigns (the “Holder”), the
principal sum of          Dollars ($        ) on August 15, 2019 and to pay interest thereon from August 14, 2009 or from the most recent Interest Payment
Date to which interest has been paid or duly provided for, semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2010, at the rate of 5.20% per annum, until the principal hereof is paid or
made available for payment, provided that any principal, and any such installment of interest, that is overdue shall 
  
  

	**	Insert in Global Securities. 

 bear interest at the rate of 5.20% per annum (to the extent that the payment of such interest shall be legally
enforceable), from the dates such amounts are due until they are paid or made available for payment, and such interest shall be payable on demand. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will,
as provided in such Indenture, be paid to the Person in whose name this Series A Senior Note (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest; provided that the interest
payable at Stated Maturity, on a Redemption Date or Repayment Date will be paid to the Person to whom principal is payable. The Regular Record Date shall be the close of business on the Business Day preceding such Interest Payment Date; provided,
that with respect to Series A Senior Notes that are not represented by one or more Global Securities, the Regular Record Date shall be the close of business on the 15th calendar day (whether or not a Business Day) preceding such Interest Payment
Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Series A Senior Note (or one or more Predecessor
Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Series Trustee, notice whereof shall be given to Holders of Series A Senior Notes not less than 10 days prior
to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Series A Senior Notes may be listed, and upon such notice as may be required by such
exchange, all as more fully provided in said Indenture. 
 Payments of interest on the Series A Senior Notes will include interest accrued to
but excluding the respective Interest Payment Dates. Interest payments for the Series A Senior Notes shall be computed and paid on the basis of a 360-day year of twelve 30-day months. In the event that any date on which interest is payable on the
Series A Senior Notes is not a Business Day, then payment of the interest payable on such date will be made on the next succeeding day that is a Business Day (and without any interest or payment in respect of any such delay), in each case with the
same force and effect as if made on the date the payment was originally payable. 
 Payment of the principal of and interest on this Series A
Senior Note will be made at the office of the Paying Agent, in the Borough of Manhattan, City and State of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private
debts, with any such payment that is due at the Stated Maturity of any Series A Senior Note, upon redemption or repurchase being made upon surrender of such Series A Senior Note to such office or agency; provided, however, that at the option of the
Company payment of interest, subject to such surrender where applicable, may be made (i) by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (ii) by wire transfer at such
place and to such account at a banking institution in the United States as may be designated in writing to the Series Trustee at least sixteen (16) days prior to the date for payment by the Person entitled thereto. 
 Reference is hereby made to the further provisions of this Series A Senior Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. 
  

 2 

 Unless the certificate of authentication hereon has been executed by the Series Trustee referred to on
the reverse hereof by manual signature, this Series A Senior Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 
  

					
	 Dated:
	 	DOMINION RESOURCES, INC.
			
		 	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

  

 3 

 [REVERSE OF 2009 SERIES A 5.20% SENIOR NOTE] 
 This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be issued in one
or more series under an Indenture dated as of June 1, 2000, between the Company and The Bank of New York Mellon (successor to JPMorgan Chase Bank, N.A. (formerly known as The Chase Manhattan Bank)) (the “Original Trustee”), as amended
by the Thirty-Eighth Supplemental and Amending Indenture dated as of November 1, 2008 (as so amended, the “Base Indenture”), by and among the Company, the Original Trustee and Deutsche Bank Trust Company Americas as Series Trustee, as
heretofore supplemented and as further supplemented by a Thirty-Ninth Supplemental Indenture dated as of August 1, 2009 (the “Thirty-Ninth Supplemental Indenture” and together with the Base Indenture, as it may be hereafter
supplemented or amended from time to time, the “Indenture,” which term shall have the meaning assigned to it in such instrument), by and between the Company and Deutsche Bank Trust Company Americas, as Trustee of the series of Securities
established thereby (herein called the “Series Trustee,” which term includes any successor series trustee for the Series A Senior Notes under the Indenture) and reference is hereby made to the Indenture for a statement of the respective
rights, limitations of rights, duties and immunities thereunder of the Company, the Original Trustee, the Series Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered.
This Security is one of the series designated on the face hereof (the “Series A Senior Notes”) which is unlimited in aggregate principal amount. 
 The Series A Senior Notes are redeemable, in whole or in part, at any time, in the manner and with the effect provided in the Indenture. 
 If an Event of Default with respect to Series A Senior Notes shall occur and be continuing, the principal of the Series A Senior Notes may be declared due and payable in the manner and with the effect provided in the
Indenture. 
 The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee for the series of Securities affected, with the consent of the Holders of a
majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the
time Outstanding, on behalf of the Holders of all Securities of such series, to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Series A Senior Note shall be conclusive and
binding upon such Holder and upon all future Holders of this Series A Senior Note and of any Series A Senior Note issued upon the registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Series A Senior Note. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Series A
Senior Note shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Series Trustee
written notice of a continuing Event of 

  

 4 

 
Default with respect to the Series A Senior Notes, the Holders of not less than a majority in principal amount of the Series A Senior Notes at the time
Outstanding shall have made written request to the Series Trustee to institute proceedings in respect of such Event of Default as Series Trustee and offered the Series Trustee reasonable indemnity, and the Series Trustee shall not have received from
the Holders of a majority in principal amount of Series A Senior Notes at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding for 60 days after receipt of such notice, request and
offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Series A Senior Note for the enforcement of any payment of principal hereof or premium, if any, or interest hereon on or after the respective due dates
expressed or provided for herein. 
 No reference herein to the Indenture and no provision of this Series A Senior Note or of the Indenture
shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Series A Senior Note at the times, place and rate, and in the coin or currency, herein
prescribed. 
 As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Series A Senior Note
is registrable in the Security Register, upon surrender of this Series A Senior Note for registration of transfer at the office or agency of the Company in any place where the principal of, premium, if any, and interest on this Series A Senior Note
are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or
more new Series A Senior Notes of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The Series A Senior Notes are issuable only in registered form without coupons in denominations of $1,000 and any greater integral multiple of $1,000. As
provided in the Indenture and subject to certain limitations therein set forth, Series A Senior Notes are exchangeable for a like aggregate principal amount of Series A Senior Notes having the same Stated Maturity and of like tenor of any authorized
denominations as requested by the Holder upon surrender of the Series A Senior Note or Series A Senior Notes to be exchanged at the office or agency of the Company. 
 No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.

 Prior to due presentment of this Series A Senior Note for registration of transfer, the Company, the Series Trustee and any agent of the
Company or the Series Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Series A Senior Note be overdue, and neither the Company, the Series Trustee nor any such agent
shall be affected by notice to the contrary. 
 All terms used in this Series A Senior Note that are defined in the Indenture shall have the
meanings assigned to them in the Indenture. 
  

 5 

 ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations: 
  

					
	TEN COM -	  	as tenants in common	 	
			
	TEN ENT -	  	as tenants by the entireties	 	
		
	JT TEN -	  	as joint tenants with rights of survivorship and not as tenants in common
			
	UNIF GIFT MIN ACT -	  	  
	 	Custodian for
		  	(Cust)	 	
			
		  	  
	 	
		  	(Minor)	 	
			
		  	Under Uniform Gifts to Minors Act of	 	
			
		  	  
	 	
		  	(State)	 	

 Additional abbreviations may also be used though not on the above list. 
                                        
                                         
                                         
                    
  

 6 

 FOR VALUE RECEIVED, the undersigned hereby sell(s) and transfer(s) unto 
  

			
	 	 	.

  

			
	 	 	.

 (please insert Social Security or other identifying number of assignee) 
  

			
	 	 	.

  

			
	 	 	.

  

			
	 	 	.

 PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE OF ASSIGNEE 
 the within Series A Senior Note and all rights thereunder, hereby irrevocably constituting and appointing 
  

			
	 	 	.

  

			
	 	 	.

  

			
	 	 	.

  
  

			
	 	 	.

  

			
	 	 	.

  

			
	 	 	.

 agent to transfer said Series A Senior Note on the books of the Company, with full power of substitution in the
premises. 
 Dated:              ,
         
  

	
	  

 NOTICE: The signature to this assignment must correspond with the name as written upon the face of the
within instrument in every particular without alteration or enlargement, or any change whatever. 
  

 7 

 EXHIBIT B 
 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated therein
referred to in the within-mentioned Indenture. 
  

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as
	Series Trustee
		
	By:	 	  

		 	Authorized Signatory

  

 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]